These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 11938937)
21. [Preparation of sustained release microspheres containing extracts from Caulis sinomenii with polylactic acid and their release property in vitro]. Zhan W; Zhang X Zhongguo Zhong Yao Za Zhi; 2010 Aug; 35(16):2142-5. PubMed ID: 21046749 [TBL] [Abstract][Full Text] [Related]
22. Pharmaceutical study of suppository formulations for improved in vivo kinetics of rifampicin. Taki H; Ogawa K; Nikai T Kekkaku; 2008 Jun; 83(6):451-6. PubMed ID: 18634449 [TBL] [Abstract][Full Text] [Related]
23. Poly(ethylene carbonate)-containing polylactic acid microparticles with rifampicin improve drug delivery to macrophages. Priemel PA; Wang Y; Bohr A; Water JJ; Yang M; Mørck Nielsen H J Pharm Pharmacol; 2018 Aug; 70(8):1009-1021. PubMed ID: 29851078 [TBL] [Abstract][Full Text] [Related]
24. Controlled release of 3',5'-diester prodrugs of 5-fluoro-2'-deoxyuridine from poly-L-lactic acid microspheres. Seki T; Kawaguchi T; Endoh H; Ishikawa K; Juni K; Nakano M J Pharm Sci; 1990 Nov; 79(11):985-7. PubMed ID: 2149864 [TBL] [Abstract][Full Text] [Related]
25. Effect of polyethylene glycol on preparation of rifampicin-loaded PLGA microspheres with membrane emulsification technique. Ito F; Fujimori H; Honnami H; Kawakami H; Kanamura K; Makino K Colloids Surf B Biointerfaces; 2008 Oct; 66(1):65-70. PubMed ID: 18585903 [TBL] [Abstract][Full Text] [Related]
26. Targeting of multiple emulsions to the lungs. Khopade AJ; Mahadik KR; Jain NK Pharmazie; 1996 Aug; 51(8):558-62. PubMed ID: 8794466 [TBL] [Abstract][Full Text] [Related]
27. Single step spray drying method to develop proliposomes for inhalation: a systematic study based on quality by design approach. Patil-Gadhe A; Pokharkar V Pulm Pharmacol Ther; 2014 Apr; 27(2):197-207. PubMed ID: 23916767 [TBL] [Abstract][Full Text] [Related]
28. Preparation and characterization of rifampicin-PLGA microspheres/sodium alginate in situ gel combination delivery system. Hu C; Feng H; Zhu C Colloids Surf B Biointerfaces; 2012 Jun; 95():162-9. PubMed ID: 22424828 [TBL] [Abstract][Full Text] [Related]
29. Preparation and properties of monodispersed rifampicin-loaded poly(lactide-co-glycolide) microspheres. Ito F; Makino K Colloids Surf B Biointerfaces; 2004 Nov; 39(1-2):17-21. PubMed ID: 15542335 [TBL] [Abstract][Full Text] [Related]
30. Treatment of spinal tuberculosis in rabbits using bovine serum albumin nanoparticles loaded with isoniazid and rifampicin. Ma R; Zhang J; Chen Z; Ma H; Liu X; Liang S; Wu P; Ge Z Neurol Res; 2022 Mar; 44(3):268-274. PubMed ID: 34581255 [TBL] [Abstract][Full Text] [Related]
31. A preclinical pharmacokinetic modeling approach to the biopharmaceutical characterization of immediate and microsphere-based sustained release pulmonary formulations of rifampicin. Doan TV; Grégoire N; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC Eur J Pharm Sci; 2013 Jan; 48(1-2):223-30. PubMed ID: 23159665 [TBL] [Abstract][Full Text] [Related]
32. Comparative evaluation of polymeric nanoparticles of rifampicin comprising Gantrez and poly(ethylene sebacate) on pharmacokinetics, biodistribution and lung uptake following oral administration. Patel MD; Date PV; Gaikwad RV; Samad A; Malshe VC; Devarajan PV J Biomed Nanotechnol; 2014 Apr; 10(4):687-94. PubMed ID: 24734521 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of hepatocellular carcinoma in mice with locally administered epirubicin-loaded poly(D, L)-lactic acid microspheres]. Zhou JY; Wang XM; Ye SF; Weng J; Hou ZQ; Zhou ZM; Zhang QQ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):690-4. PubMed ID: 17121233 [TBL] [Abstract][Full Text] [Related]
34. Lipid microsphere formulation containing rifampicin targets alveolar macrophages. Takenaga M; Ohta Y; Tokura Y; Hamaguchi A; Igarashi R; Disratthakit A; Doi N Drug Deliv; 2008; 15(3):169-75. PubMed ID: 18379929 [TBL] [Abstract][Full Text] [Related]
35. [Characteristics of CDDP-PLA microspheres in vitro and in vivo]. Liu ZK; Wei SL; Lan CQ; Su DY Yao Xue Xue Bao; 1993; 28(10):792-7. PubMed ID: 8009994 [TBL] [Abstract][Full Text] [Related]
37. Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages. Hirota K; Hasegawa T; Hinata H; Ito F; Inagawa H; Kochi C; Soma G; Makino K; Terada H J Control Release; 2007 May; 119(1):69-76. PubMed ID: 17335927 [TBL] [Abstract][Full Text] [Related]
38. Studies on a reverse micelle-lamellar phase transition based depot preparation of rifampicin. Uppadhyay AK; Omray LK; Khopade AJ; Jain NK Pharmazie; 1997 Dec; 52(12):961-2. PubMed ID: 9442561 [No Abstract] [Full Text] [Related]
39. Preparation and evaluation of biodegradable microspheres containing a new potent osteogenic compound and new synthetic polymers for sustained release. Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S Int J Pharm; 2010 Jun; 392(1-2):42-50. PubMed ID: 20227474 [TBL] [Abstract][Full Text] [Related]